ZHIFEI-BIOL(SZ:300122) Xin Lang Zheng Quan·2025-11-24 01:20Core Insights - On November 21, Zhifei Biological experienced a decline of 3.58% with a trading volume of 571 million yuan [1] - The company reported a net financing outflow of 16.49 million yuan on the same day, with a total financing and securities balance of 1.387 billion yuan [1][2] - For the period from January to September 2025, Zhifei Biological's revenue decreased by 66.53% year-on-year, amounting to 7.627 billion yuan, while the net profit attributable to shareholders was -1.206 billion yuan, a decrease of 156.10% [2] Financing and Securities - On November 21, Zhifei Biological had a financing buy-in of 63.06 million yuan, with a current financing balance of 1.384 billion yuan, representing 2.86% of the circulating market value [1] - The financing balance is below the 30th percentile level over the past year, indicating a low position [1] - The company had a securities lending balance of 3.5773 million yuan, which is above the 70th percentile level over the past year, indicating a high position [1] Shareholder Information - As of November 10, the number of shareholders for Zhifei Biological increased to 133,100, a rise of 1.19% [2] - The average number of circulating shares per shareholder decreased by 1.17% to 10,624 shares [2] - Major institutional shareholders have reduced their holdings, with Hong Kong Central Clearing Limited holding 33.5608 million shares, down by 2.7888 million shares [2]